DYSIS View Brochure

Product catalog summary

Introduction
Colposcopy is undergoing significant changes with the introduction of advanced technologies like DYSIS View and DYSISmap™, which offer superior image quality and enhanced diagnostic capabilities. These innovations are designed to improve biopsy accuracy and patient management in colposcopy services.

Product Features
The DYSIS View system is compact, lightweight, and easy to store, making it ideal for straightforward biopsy and treatment procedures. It includes an intuitive color-coded map, DYSISmap™, which quantifies acetowhitening by measuring its onset, intensity, and persistence. The system also features SMARTtrack, a longitudinal tracking system that aids in conservative management options.

Clinical Recommendations
In 2018, NICE recommended the continued adoption of colposcopy using DYSIS with DYSISmap due to its ability to detect more clinically important lesions compared to traditional colposcopy. This recommendation reinforces previous guidance from 2012. Additionally, the NHSCSP's 2016 publication recognized the clinical and financial benefits of the DYSIS Colposcope.

Impact of HPV Screening Changes
The NHS cervical screening program is transitioning to hrHPV testing as the primary screening method by 2020, which is expected to increase colposcopy referrals by 54% within two years. This change necessitates that colposcopy clinics prepare for an influx of new patient populations, particularly those with persistent hrHPV+ and negative cytology results.

Benefits of DYSIS View
DYSIS View with DYSISmap™ enhances the detection of high-grade cervical disease, increasing detection rates by over 30% in all referrals and up to 50% in certain populations. It facilitates targeted biopsies, reduces unnecessary procedures, and supports longitudinal monitoring for conservative management. The system's high negative predictive value provides confidence in discharging patients appropriately.

Conclusion
DYSIS View and DYSISmap™ represent a new standard of care in colposcopy, offering tools that improve diagnostic accuracy and patient management. Clinics are encouraged to adopt these technologies to handle the anticipated increase in colposcopy referrals effectively.

Catalog excerpts

STANDARDISING COLPOSCOPY dysis Smart Colposcopy Quantiﬁed acetowhitening DYSISmap™ is our intuitive colour coded map which measures the onset, intensity and persistence of acetowhitening. Guided biopsy markers Increase precision and improve biopsy accuracy. Is your service ready? Superior documentation SMARTtrack is our longitudinal tracking system, revolutionising conservative management options. Superior image quality Compact design for straightforward biopsy and treatment. Lightweight and manoeuvrable. Easy to store. DYSIS View: The new standard of care in Colposcopy On-board computer Full colposcopy database. WiFi connectivity. Patient report (PDF) exports. Connection to external ﬁles stores. Find out more about DYSIS View and DYSISmapTM Get in touch [email protected] www.dysismedical.com For more information call +44 (0)131 516 3944 DETECT In 2018, NICE concluded that colposcopy using DYSIS with the adjunctive DYSISmap detects more clinically important lesions than colposcopy alone. As a result, NICE recommends its continued adoption, reinforcing its previous 2012 guidance. In March 2016, NHSCSP published the 3rd edition of Publication no.20, Colposcopy and Programme Management. Publication 20, which advises on the latest advancements in cervical screening, has recognised the DYSIS Colposcope for its clinical and financial benefits. ¹ Rebolj M, Rimmer J, Denton K, et al. Primary cervical screening with high risk human papillomavirus testing: observational study. BMJ. 2019 Feb 6;364:l240 ² DYSIS bibliography available at www.dysismedical.com/clinical-evidence Product images are shown for illustration purposes. Actual product may vary due to product enhancements.

Open the catalog to page 1

The NHS cervical screening programme is changing. By 2020, hrHPV testing will become the primary screening test. hrHPV screening achieves a greater sensitivity than cytology leading to the detection of 50% more CIN 2+.¹ Why choose DYSIS View? DYSIS View with DYSISmap™ is the most eﬀective way to detect cervical disease, improving patient management decisions and providing added conﬁdence to discharge patients appropriately. How will this impact your colposcopy service? How can DYSIS View help your clinic eﬀectively manage change? The new HPV primary screening programme will result in a 54% increase...

Open the catalog to page 2

Open the catalog to page 3